NasdaqGS - Delayed Quote USD

Omnicell, Inc. (OMCL)

28.43 +0.25 (+0.89%)
At close: April 23 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Randall A. Lipps Founder, Executive Chairman, President & CEO 1.85M -- 1957
Mr. Nchacha E. Etta Executive VP & CFO 480.21k -- 1972
Mr. Corey J. Manley Executive VP, Chief Legal & Administrative Officer and Corporate Secretary 715.33k -- 1978
Ms. Minoo Mortazavi Senior Vice President of Global Operations -- -- --
Mr. Brian H. Nutt VP, Chief Accounting Officer & Corporate Controller -- -- 1970
Mr. Giri Chodavarapu Senior VP & Chief Information Officer -- -- --
Ms. Kathleen Nemeth Senior Vice President of Investor Relations -- -- --
Mr. Maximo Rocha Senior VP & Chief People Officer -- -- --
Mr. Joseph Brian Spears Executive Adviser -- -- 1960
Ms. Sara Dalmasso Senior VP & GM of International -- -- --

Omnicell, Inc.

4220 North Freeway
Suite 301
Fort Worth, TX 76137
United States
877 415 9990 https://www.omnicell.com
Sector: 
Healthcare
Full Time Employees: 
3,650

Description

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Corporate Governance

Omnicell, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024
Omnicell, Inc. Earnings Call

Related Tickers